New Delhi, India, July 30, 2024: Strides Pharma Science Ltd . announced its consolidated financial results for the quarter (Q1FY25) ended June 30, 2024. Adjusted PAT = PAT from continuing operations without JV share and exceptional items Arun Kumar, Founder & Executive Chairperson, and , Badree Komandur MD & Group CEO, commented on the performance and …
News Stories